| TROSPIUM CHLORIDE; XANOMELINE TARTRATE | None | ||
| 20MG;50MG, 20MG;100MG, 30MG;125MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults. | |||
|
Yes
| |||
| COBENFY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||
| ******* *** ************ *** ********* ** ********* *********** ** ********** ******** ********** | ******* *** ************ *** ********* ** ********* *********** ** ********** ******** ********** | ******* *** ************ *** ********* ** ********* *********** ** ********** ******** ********** | ******* *** ************ *** ********* ** ********* *********** ** ********** ******** ********** | ******* *** ************ *** ********* ** ********* *********** ** ********** ******** ********** | ************ *** ******* *** ********* ** ********* *********** ** ********** ******** ********** | ************ *** ******* *** ******** ********* *********** ** ********** ******** ********** | ************ *** ******* *** ******** ********* *********** ** ********** ******** ********** | ************ *** ******* *** ******** ********* *********** ** ********** ******** ********** | ************ *** ******* *** ******** ********* *********** ** ********** ******** ********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|